Mondelez International, Inc. MDLZ
Verdict: Sell. Fair value $53.97 against a price of $53.74 on 6 Jan 2026.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Net Income shows significant year-over-year volatility ($4.30B in 2021, $2.72B in 2022, $4.96B in.... The OCF/Net Income ratio, while strong on average (1.15), showed a dip below 1.0 in 2023 (0.95)....
Main risks
- Sharp Revenue Deceleration: Annual revenue growth has slowed dramatically from over 14% in the prior period to just 1.2% in the most recent year, signaling potential market saturation or competitive pressures.
- High Leverage: The estimated Debt-to-EBITDA ratio is over 5x. This level of leverage is high for a consumer staples company and could pose a risk, especially if cash flows continue to weaken.
- Poor Returns on Capital: The TTM ROIC is very low at 4.9%, and the estimated 3-year ROIIC of 5.5% suggests that recent capital investments are not generating adequate returns, raising concerns about capital allocation efficiency.
- Net Income shows significant year-over-year volatility ($4.30B in 2021, $2.72B in 2022, $4.96B in...
- Intense competitive environment
- Net Income shows significant year-over-year volatility ($4.30B in 2021, $2.72B in 2022, $4.96B in 2023), which is not reflected in the more stable Operating Cash Flow. This suggests GAAP earnings are heavily influenced by large, non-cash, one-time items, reducing their reliability for assessing core performance.